FINANCIAL PERFORMANCE ANALYSIS Revenue Metrics: • Annual Collections: $1,300,000+ in 2025 • Cash Revenue Composition: 60% ($780,000+ cash-based services) • Insurance Revenue: 40% ($520,000+ diversified payor mix) • Patient Base: 5,000+ active patients (3-year period) • Daily New Patient Inquiries: 12-17 (demand exceeding capacity) OPERATIONAL EFFICIENCY INDICATORS Capacity Utilization: • Current Status: 100% capacity with waitlist • Facility: 1,600 SF medical space (optimal space-to-revenue ratio) • Clinical Infrastructure: 5 exam rooms + procedure suite + lab + ultrasound • Staffing Model: 3 experienced Nurse Practitioners + stable support team Market Position: • Market Tenure: 17+ years established presence • Geographic Advantage: Affluent Southeastern metro suburb • Specialty Focus: GYN-only practice (reduced competition) • Referral Network: Multi-state patient draw established REVENUE DIVERSIFICATION ANALYSIS High-Margin Service Lines: • Hormone Therapy (cash-based) • Weight Management Programs (cash-based) • Aesthetic Services (cash-based) • Traditional GYN Services (insurance reimbursed) Risk Mitigation Factors: • 60% cash revenue reduces reimbursement dependency • Diversified payor mix minimizes single-source risk • Established patient loyalty (17-year track record) • Essential healthcare services (recession-resistant) GROWTH SCALABILITY METRICS Immediate Expansion Opportunities: • Patient Capacity: Currently waitlisted (immediate revenue potential) • Provider Addition: Infrastructure supports additional clinicians • Service Expansion: Pelvic floor therapy, wellness memberships • Digital Marketing: Untapped potential for cash-service growth QUANTIFIABLE ADVANTAGES • Patient Retention: 5,000+ active patients demonstrate loyalty • Demand Validation: 12-17 daily inquiries confirm market strength • Cash Flow Stability: 60% cash revenue provides predictable income • Operational Leverage: Capacity constraints indicate pricing power TRANSITION STRUCTURE Owner transitioning to semi-retirement with structured handoff support including clinical consultation to ensure revenue continuity and growth trajectory maintenance. DUE DILIGENCE PACKAGE Comprehensive Confidential Business Review is available to qualified buyers under NDA.